BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ángela Rojas, Jose A. Del Campo, Sophie Clement, Matthieu Lemasson, Marta García-Valdecasas, Antonio Gil-Gómez, Isidora Ranchal, Birke Bartosch, Juan D. Bautista, Arielle R. Rosenberg, Francesco Negro, Manuel Romero-Gómez. Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host TargetsScientific Reports 2016; 6(1) doi: 10.1038/srep31777
2
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
3
Roland Ivanyi-Nagy, Jean-Luc Darlix. FuzzinessAdvances in Experimental Medicine and Biology 2012; 725: 142 doi: 10.1007/978-1-4614-0659-4_9
4
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
5
Saba Riaz, Muhammad Faisal Bashir, Saleem Haider, Naeem Rahid. Association of genotypes with viral load and biochemical markers in HCV-infected Sindhi patientsBrazilian Journal of Microbiology 2016; 47(4): 980 doi: 10.1016/j.bjm.2016.07.014
6
Claire Gondeau, Georges Philippe Pageaux, Dominique Larrey. Hepatitis C virus infection: Are there still specific problems with genotype 3?World Journal of Gastroenterology 2015; 21(42): 12101-12113 doi: 10.3748/wjg.v21.i42.12101
7
Camila Ripoll Kappel, Nélson A. Kretzmann, Mário Reis Álvares-da-Silva. IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative StudyInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/698905
8
Stefan G. Hübscher. Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challengesLiver Transplantation 2011; 17(12): 1374 doi: 10.1002/lt.22452
9
Amal A Mohamed, Samah A Loutfy, James D Craik, Abdel Gawad M Hashem, Ibrahem Siam. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinomaVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-496
10
Lokesh P. Tripathi, Hiroto Kambara, Kohji Moriishi, Eiji Morita, Takayuki Abe, Yoshio Mori, Yi-An Chen, Yoshiharu Matsuura, Kenji Mizuguchi. Proteomic Analysis of Hepatitis C Virus (HCV) Core Protein Transfection and Host Regulator PA28γ Knockout in HCV Pathogenesis: A Network-Based StudyJournal of Proteome Research 2012; 11(7): 3664 doi: 10.1021/pr300121a
11
Mario Frías, Antonio Rivero-Juárez, Isabel Machuca, Ángela Camacho, Antonio Rivero. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunitiesExpert Review of Precision Medicine and Drug Development 2020; 5(4): 253 doi: 10.1080/23808993.2020.1764346
12
Á. Rojas, J. A. del Campo, M. Maraver, R. Aparcero, M. García-Valdecasas, M. Diago, I. Carmona, R. J. Andrade, R. Solà, M. Romero-Gómez. Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expressionin vivoandin vitroJournal of Viral Hepatitis 2014; 21(1): 19 doi: 10.1111/jvh.12209
13
Wen-Cheng Li, Yi-Yen Lee, I-Chuan Chen, Cheng Sun, Feng-Hsiang Chiu, Chung-Hsun Chuang. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by ageLiver International 2013; 33(8): 1194 doi: 10.1111/liv.12224
14
Marcela Pezzoto Laurito, Edison Roberto Parise. Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysisThe Brazilian Journal of Infectious Diseases 2013; 17(5): 555 doi: 10.1016/j.bjid.2013.02.009
15
Eman A. Sabet, Asmaa N. Mohammad, Laila M. Yousef, Ahmed R. H. Ahmed, Abeer Sheneef. Insulin Resistance, Visceral Adiposity Index and TyG Index in Genotype-4 Chronic HCV Patients and Their Relation to Hepatic HistopathologyOpen Journal of Gastroenterology 2016; 6(10): 249 doi: 10.4236/ojgas.2016.610030
16
Alessio Aghemo, Gian Maria Prati, Maria Grazia Rumi, Roberta Soffredini, Roberta D'Ambrosio, Emanuela Orsi, Stella De Nicola, Elisabetta Degasperi, Valeria Grancini, Massimo Colombo. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis CHepatology 2012; 56(5): 1681 doi: 10.1002/hep.25867
17
Geneviève F. Desrochers, Allison R. Sherratt, David R. Blais, Neda Nasheri, Zhibin Ning, Daniel Figeys, Natalie K. Goto, John Paul Pezacki. Profiling Kinase Activity during Hepatitis C Virus Replication Using a Wortmannin ProbeACS Infectious Diseases 2015; 1(9): 443 doi: 10.1021/acsinfecdis.5b00083
18
Heather L. Stevenson, Netanya S. Utay. Hepatic steatosis in HCV-infected persons in the direct-acting antiviral eraTropical Diseases, Travel Medicine and Vaccines 2016; 2(1) doi: 10.1186/s40794-016-0038-5
19
Lokesh P. Tripathi, Hiroto Kambara, Yi-An Chen, Yorihiro Nishimura, Kohji Moriishi, Toru Okamoto, Eiji Morita, Takayuki Abe, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Understanding the Biological Context of NS5A–Host Interactions in HCV Infection: A Network-Based ApproachJournal of Proteome Research 2013; 12(6): 2537 doi: 10.1021/pr3011217
20
Alessandro Federico, Mario Masarone, Marco Romano, Marcello Dallio, Valerio Rosato, Marcello Persico. Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective StudyHepatitis Monthly 2015; 15(6) doi: 10.5812/hepatmon.15(6)2015.18640
21
Woo Jin Chung. Chronic Hepatitis C and Insulin ResistanceThe Korean Journal of Gastroenterology 2012; 59(4): 268 doi: 10.4166/kjg.2012.59.4.268
22
Maria Perticone, Sofia Miceli, Raffaele Maio, Benedetto Caroleo, Angela Sciacqua, Eliezer Joseph Tassone, Laura Greco, Orietta Staltari, Giorgio Sesti, Francesco Perticone. Chronic HCV infection increases cardiac left ventricular mass index in normotensive patientsJournal of Hepatology 2014; 61(4): 755 doi: 10.1016/j.jhep.2014.05.032
23
Emilio González-Reimers, Geraldine Quintero-Platt, Melchor Rodríguez-Gaspar, Remedios Alemán-Valls, Onán Pérez-Hernández, Francisco Santolaria-Fernández. Liver steatosis in hepatitis C patientsWorld Journal of Hepatology 2015; 7(10): 1337-1346 doi: 10.4254/wjh.v7.i10.1337
24
W. Chen, G. Tomlinson, M. Krahn, J. Heathcote. Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinomaJournal of Viral Hepatitis 2012; 19(8): 574 doi: 10.1111/j.1365-2893.2012.01583.x
25
Chandrasekar Palaniswamy, Wilbert S. Aronow, Rishi Sukhija, Tarun Chugh, Navi Ramdeen, Kumar Kalapatapu, Melvin B. Weiss, Anthony L. Pucillo, Craig E. Monsen. Major Adverse Cardiac Events in Patients With Hepatitis C Infection Treated With Bare-Metal Versus Drug-Eluting StentsClinical Cardiology 2010; 33(6): 367 doi: 10.1002/clc.20764
26
A. C. Cardoso, R. M. Perez, C. de Figueiredo-Mendes, N. Carvalho Leite, H. S. Moraes-Coelho, C. A. Villela-Nogueira. Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP)Journal of Viral Hepatitis 2018; 25(11): 1244 doi: 10.1111/jvh.12930
27
Marco Arrese, Arnoldo Riquelme, Alejandro Soza. Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implicationsAnnals of Hepatology 2010; 9: S112 doi: 10.1016/S1665-2681(19)31735-1
28
Kamila Wójcik, Anna Piekarska, Alina Dąbrowicz, Marta Stasiak, Katarzyna Gawryś, Elżbieta Jabłonowska. Hepatic Expression of Phosphorylated Kinase Akt and Glycogen Synthase Kinase-3 Isoforms in Patients with Chronic Hepatitis CViral Immunology 2019; 32(4): 179 doi: 10.1089/vim.2018.0141
29
Paul Lamb, Stephen Harrison. Metabolic Syndrome and HCV: Where Do We Stand in 2010?Current Hepatitis Reports 2010; 9(3): 133 doi: 10.1007/s11901-010-0044-4
30
Keyur Patel, Alexander J Thompson, Wan-Long Chuang, Chuan-Mo Lee, Chen-Yuan Peng, Ganesananthan Shanmuganathan, Satawat Thongsawat, Tawesak Tanwandee, Varocha Mahachai, Chutima Pramoolsinsap, Mong Cho, Kwang Hyup Han, Samir R Shah, Graham R Foster, Paul J Clark, Erik Pulkstenis, G. Mani Subramanian, John G McHutchison. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patientsJournal of Gastroenterology and Hepatology 2011; 26(7): 1182 doi: 10.1111/j.1440-1746.2011.06722.x
31
Marianna Lakatos, Krisztina Hagymási, Gabriella Lengyel. Fatty liver and hepatitis C virus infectionOrvosi Hetilap 2011; 152(38): 1513 doi: 10.1556/OH.2011.29209
32
M Wiśniewska-Ligier, A Konopka, T Woźniakowska-Gęsicka. Lipid and carbohydrate parameters in children with chronic hepatitis CAdvances in Medical Sciences 2011; 56(2): 180 doi: 10.2478/v10039-011-0048-5
33
Walid Sasi, Anup K. Sharma, Kefah Mokbel. The Role of Suppressors of Cytokine Signalling in Human NeoplasmsMolecular Biology International 2014; 2014: 1 doi: 10.1155/2014/630797
34
Lokesh P. Tripathi, Chikako Kataoka, Shuhei Taguwa, Kohji Moriishi, Yoshio Mori, Yoshiharu Matsuura, Kenji Mizuguchi. Network based analysis of hepatitis C virus Core and NS4B protein interactionsMolecular BioSystems 2010; 6(12): 2539 doi: 10.1039/c0mb00103a
35
Luigi E Adinolfi, Luciano Restivo, Aldo Marrone. The predictive value of steatosis in hepatitis C virus infectionExpert Review of Gastroenterology & Hepatology 2013; 7(3): 205 doi: 10.1586/egh.13.7
36
Fadi Rzouq, Mojtaba Olyaee, Fares Alahdab. Statins and Hepatitis C Virus Infection: An Old Therapy With New ScopeThe American Journal of the Medical Sciences 2014; 348(5): 426 doi: 10.1097/MAJ.0000000000000291